REQUEST A DEMO
Total
USD $0.00
View basket Checkout now
Search more companies

Olipass Corporation (South Korea)

Main Activities: Scientific Research and Development Services
Full name: Olipass Corporation Profile Updated: July 04, 2023
Buy our report for this company USD 29.95 Most recent financial data: 2022 Available in: English Download a sample report

Olipass Corporation is engaged in provision of nucleic acid biotechnology. The company offers products such as artificial nuclease therapeutic agents. Olipass Corporation was incorporated in 2006 and s based in Yongin, Douth Korea.

Headquarters
20th Floor, 16-4, Dongbaekjungang-ro 16beon-gil Giheung-gu Yongin-si Gyeonggi
Yongin; Gyeonggi;

Contact Details: Purchase the Olipass Corporation report to view the information.

Basic Information
Total Employees:
Purchase the Olipass Corporation report to view the information.
Outstanding Shares:
Purchase the Olipass Corporation report to view the information.
Registered Capital:
Purchase the Olipass Corporation report to view the information.
Incorporation Date:
November 16, 2006
Key Executives
Purchase this report to view the information.
President
Purchase this report to view the information.
Auditor
Purchase this report to view the information.
Vice President
Purchase this report to view the information.
Vice President
Purchase this report to view the information.
Vice President
Company Performance
Financial values in the chart are available after Olipass Corporation report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency KRW. Absolute financial data is included in the purchased report.
Net sales revenue
757.03%▲
Total operating revenue
757.03%▲
Operating profit (EBIT)
3.67%▲
EBITDA
3.67%▲
Net Profit (Loss) for the Period
8.07%▲
Total assets
-40.51%▼
Total equity
-55.16%▼
Operating Profit Margin (ROS)
42179.08%▲
Net Profit Margin
44754.87%▲
Return on Equity (ROE)
-76.21%▼
Debt to Equity Ratio
-2.45%▼
Quick Ratio
-2.14%▼
Cash Ratio
0.4%▲

To view more information, Request a demonstration of the EMIS service

USD 29.95
Buy this company report
Need ongoing access to company, industry or country information?
Request a demo